{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:58:49Z","timestamp":1770749929733,"version":"3.50.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2020.01.052","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T08:11:56Z","timestamp":1580112716000},"page":"2378-2386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Transcutaneous immunization with a nontypeable Haemophilus influenzae dual adhesin-directed immunogen induces durable and boostable immunity"],"prefix":"10.1016","volume":"38","author":[{"given":"Laura A.","family":"Novotny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren O.","family":"Bakaletz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.01.052_b0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation","volume":"14","author":"Pasparakis","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2020.01.052_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4161\/hv.34299","article-title":"Tailored immunity by skin antigen-presenting cells","volume":"11","author":"Levin","year":"2015","journal-title":"Human Vacc Immunotherap"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2020.01.052_b0015","doi-asserted-by":"crossref","first-page":"D116","DOI":"10.1016\/j.vaccine.2011.11.090","article-title":"\u201cIDEAL\u201d vaccines for resource poor settings","volume":"29","author":"Levine","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.052_b0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2005.12.003","article-title":"Needle-free vaccine delivery","volume":"58","author":"Giudice","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2020.01.052_b0025","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3109\/10717544.2014.935532","article-title":"Permeation enhancer strategies in transdermal drug delivery","volume":"23","author":"Marwah","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.vaccine.2020.01.052_b0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1567201811666140515145329","article-title":"Physical means of stratum corneum barrier manipulation to enhance transdermal drug delivery","volume":"12","author":"Parhi","year":"2015","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.vaccine.2020.01.052_b0035","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1080\/21645515.2018.1461296","article-title":"Noninvasive vaccination against infectious diseases","volume":"14","author":"Zheng","year":"2018","journal-title":"Human Vacc Immunotherap"},{"key":"10.1016\/j.vaccine.2020.01.052_b0040","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1128\/CVI.00090-15","article-title":"Therapeutic transcutaneous immunization with a band-aid vaccine resolves experimental otitis media","volume":"22","author":"Novotny","year":"2015","journal-title":"Clin Vacc Immunol: CVI"},{"key":"10.1016\/j.vaccine.2020.01.052_b0045","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00563-16","article-title":"Transcutaneous immunization with a band-aid prevents experimental otitis media in a polymicrobial model","volume":"24","author":"Novotny","year":"2017","journal-title":"Clin Vacc Immunol: CVI"},{"key":"10.1016\/j.vaccine.2020.01.052_b0050","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14760584.2018.1484286","article-title":"Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development","volume":"17","author":"Jalalvand","year":"2018","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2020.01.052_b0055","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1080\/21645515.2016.1174354","article-title":"Why we need a vaccine for non-typeable Haemophilus influenzae","volume":"12","author":"Cerquetti","year":"2016","journal-title":"Human Vacc Immunotherap"},{"key":"10.1016\/j.vaccine.2020.01.052_b0060","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/CVI.00089-15","article-title":"Vaccines for nontypeable Haemophilus influenzae: the future is now","volume":"22","author":"Murphy","year":"2015","journal-title":"Clin Vacc Immunol: CVI"},{"key":"10.1016\/j.vaccine.2020.01.052_b0065","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1002\/1873-3468.12351","article-title":"Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen","volume":"590","author":"Duell","year":"2016","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2020.01.052_b0070","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1128\/IAI.73.3.1635-1643.2005","article-title":"Demonstration of Type IV pilus expression and a twitching phenotype by Haemophilus influenzae","volume":"73","author":"Bakaletz","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.01.052_b0075","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1365-2958.2007.05864.x","article-title":"The PilA protein of non-typeable Haemophilus influenzae plays a role in biofilm formation, adherence to epithelial cells and colonization of the mammalian upper respiratory tract","volume":"65","author":"Jurcisek","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2020.01.052_b0080","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1128\/JB.06540-11","article-title":"Biological roles of nontypeable Haemophilus influenzae type IV pilus proteins encoded by the pil and com operons","volume":"194","author":"Carruthers","year":"2012","journal-title":"J Bacteriol"},{"issue":"19","key":"10.1016\/j.vaccine.2020.01.052_b0085","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1128\/JB.01022-15","article-title":"Type IV pilus expression is upregulated in nontypeable Haemophilus influenzae biofilms formed at the temperature of the human nasopharynx","volume":"198","author":"Mokrzan","year":"2016","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2020.01.052_b0090","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00254-19","article-title":"In silico modeling of biofilm formation by nontypeable Haemophilus influenzae in vivo","volume":"4","author":"Brown","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.vaccine.2020.01.052_b0095","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1128\/IAI.68.4.2119-2128.2000","article-title":"Epitope mapping of the outer membrane protein P5-homologous fimbrin adhesin of nontypeable Haemophilus influenzae","volume":"68","author":"Novotny","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.01.052_b0100","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/IAI.74.2.830-838.2006","article-title":"Nontypeable Haemophilus influenzae adheres to intercellular adhesion molecule 1 (ICAM-1) on respiratory epithelial cells and upregulates ICAM-1 expression","volume":"74","author":"Avadhanula","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.01.052_b0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/IAI.00980-07","article-title":"A carcinoembryonic antigen-related cell adhesion molecule 1 homologue plays a pivotal role in nontypeable Haemophilus influenzae colonization of the chinchilla nasopharynx via the outer membrane protein P5-homologous adhesin","volume":"76","author":"Bookwalter","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.01.052_b0110","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1006\/mpat.1996.0067","article-title":"Selective adherence of non-typeable Haemophilus influenzae (NTHi) to mucus or epithelial cells in the chinchilla Eustachian tube and middle ear","volume":"21","author":"Miyamoto","year":"1996","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2020.01.052_b0115","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1128\/iai.62.5.2002-2020.1994","article-title":"Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A","volume":"62","author":"Sirakova","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.01.052_b0120","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00215-18","article-title":"The mucosal vaccine adjuvant LT(R192G\/L211A) or dmLT","volume":"3","author":"Clements","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.vaccine.2020.01.052_b0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.vaccine.2009.08.017","article-title":"Epitope mapping immunodominant regions of the PilA protein of nontypeable Haemophilus influenzae (NTHI) to facilitate the design of two novel chimeric vaccine candidates","volume":"28","author":"Novotny","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.052_b0130","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.171.4.1978","article-title":"The fourth surface-exposed region of the outer membrane protein P5-homologous adhesin of nontypeable Haemophilus influenzae is an immunodominant but nonprotective decoying epitope","volume":"171","author":"Novotny","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.01.052_b0135","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1016\/S0264-410X(02)00306-7","article-title":"Detection and characterization of pediatric serum antibody to the OMP P5-homologous adhesin of nontypeable Haemophilus influenzae during acute otitis media","volume":"20","author":"Novotny","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.052_b0140","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1128\/JB.187.13.4627-4636.2005","article-title":"Genomic sequence of an otitis media isolate of nontypeable Haemophilus influenzae: comparative study with H. influenzae serotype d, strain KW20","volume":"187","author":"Harrison","year":"2005","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2020.01.052_b0145","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/mi.2011.6","article-title":"Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae","volume":"4","author":"Novotny","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2020.01.052_b0150","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1128\/IAI.71.8.4691-4699.2003","article-title":"Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx","volume":"71","author":"Kyd","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.01.052_b0155","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1128\/IAI.67.6.2746-2762.1999","article-title":"Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection","volume":"67","author":"Bakaletz","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.01.052_b0160","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1016\/j.vaccine.2006.03.021","article-title":"Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae","volume":"24","author":"Novotny","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.052_b0165","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1128\/IAI.68.5.2756-2765.2000","article-title":"Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge","volume":"68","author":"Kennedy","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.01.052_b0170","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1164\/rccm.201011-1783OC","article-title":"Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways","volume":"183","author":"Brandtzaeg","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2020.01.052_b0175","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1016\/j.vaccine.2012.10.033","article-title":"Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization","volume":"31","author":"Novotny","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.052_b0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000071154","article-title":"Anatomy of the nasal cavity in the chinchilla","volume":"174","author":"Jurcisek","year":"2003","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.vaccine.2020.01.052_b0185","unstructured":"Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0 through 18 years - United States; 2009. MMWR2008."},{"key":"10.1016\/j.vaccine.2020.01.052_b0190","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1177\/106002809603001114","article-title":"Management of otitis media with effusion in young children","volume":"30","author":"Paap","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.vaccine.2020.01.052_b0195","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1128\/JB.01935-06","article-title":"Biofilms formed by nontypeable Haemophilus influenzae in vivo contain both double-stranded DNA and type IV pilin protein","volume":"189","author":"Jurcisek","year":"2007","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2020.01.052_b0200","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer's-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2020.01.052_b0205","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1016\/j.vaccine.2015.05.012","article-title":"Recent insights into cutaneous immunization: How to vaccinate via the skin","volume":"33","author":"Engelke","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.052_b0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2015.11.019","article-title":"Microneedle patches for vaccination in developing countries","volume":"240","author":"Arya","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2020.01.052_b0215","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1586\/erv.09.113","article-title":"10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix","volume":"8","author":"Prymula","year":"2009","journal-title":"Expert Rev Vacc"},{"issue":"8","key":"10.1016\/j.vaccine.2020.01.052_b0220","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00022-19","article-title":"Design and characterization of Protein E-PilA, a candidate fusion antigen for nontypeable Haemophilus influenzae vaccine","volume":"87","author":"Blais","year":"2019","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2020.01.052_b0225","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00345-19","article-title":"A Protein E-PilA fusion protein shows vaccine potential against nontypeable Haemophilus influenzae in Mice and Chinchillas","volume":"87","author":"Ysebaert","year":"2019","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.01.052_b0230","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1016\/j.vaccine.2016.04.051","article-title":"Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults","volume":"34","author":"Leroux-Roels","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.052_b0235","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1016\/j.vaccine.2019.07.100","article-title":"Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial","volume":"37","author":"Wilkinson","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.052_b0240","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/j.vaccine.2019.04.041","article-title":"Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine","volume":"37","author":"Van Damme","year":"2019","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20300785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20300785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:40:00Z","timestamp":1759401600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20300785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X20300785"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcutaneous immunization with a nontypeable Haemophilus influenzae dual adhesin-directed immunogen induces durable and boostable immunity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}